Profiel
Penny S.
Toren worked as a Senior VP-Regulatory Affairs & Program Management at Vallon Pharmaceuticals, Inc. from 2018 to 2022.
She completed her undergraduate degree at Florida Atlantic University and her graduate degree at New York Medical College.
Eerdere bekende functies van Penny S. Toren
| Bedrijven | Functie | Einde |
|---|---|---|
| GRI BIOPAR | Algemeen Adviseur | 19-04-2022 |
Opleiding van Penny S. Toren
| Florida Atlantic University | Undergraduate Degree |
| New York Medical College | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Vallon Pharmaceuticals, Inc.
 Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vallon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on the development and commercialization of proprietary biopharmaceutical products. The firm's primary product is Abuse-Deterrent Amphetamine Immediate and its product pipeline includes ADAIR, ADMIR, ADHD, and Narcolepsy. The company was founded by David C. Baker on January 11, 2018 and is headquartered in Philadelphia, PA. | Health Technology |
